📖Definition
The question of who deserves the final word in a human-AI collaboration — and the fundamental position of the Augmanitai concept: The final word always lies with the human. Related to Axiom 1 (Asymmetric Responsibility), AUG-0219 (The Decision Handoff), and Axiom 19 (Human Veto Right).
📖Definition (DE)
Die Frage, wem in einer Mensch-KI-Zusammenarbeit das letzte Wort gebührt — und die Grundposition des Augmanitai-Konzepts: Das letzte Wort liegt immer beim Menschen. Steht in Verbindung mit Axiom 1 (Asymmetrische Verantwortung), AUG-0219 (The Decision Handoff) und Axiom 19 (Menschliches Vetorecht).
🧠 What the Person Experiences · Was die Person erlebt
I experience a shift—something clicks into clarity. There's a moment of recognition where abstract becomes concrete, and suddenly the pattern I was sensing becomes visible. It feels like learning something about myself.
Ich erlebe einen Wandel—etwas springt in Klarheit. Es gibt einen Moment der Erkennung, in dem Abstraktes konkret wird, und plötzlich wird das Muster, das ich spürte, sichtbar. Es fühlt sich an wie das Erlernen von etwas über mich selbst.
🔄 How It Develops Over Time · Wie es sich entwickelt
Week1: Initial awareness of the concept. Month1: Deliberate practice and exploration across contexts. Month6: Integration becomes intuitive and automatic, functioning as second nature.
Woche1: Anfängliches Bewusstsein des Konzepts. Monat1: Bewusste Praxis über verschiedene Kontexte. Monat6: Integration wird intuitiv und automatisch, funktioniert als zweite Natur.
💼 In the Workplace · Am Arbeitsplatz
A startup founder uses AI to analyze competitor strategies and identify market gaps while preparing pitch deck revisions.
Ein Startup-Gründer nutzt KI, um Konkurrenzstrategien zu analysieren und Marktlücken zu identifizieren, während er die Pitch Deck überarbeitet.
🌎 Translations (10 Languages)
🌐 Français (FR)
La question de savoir qui mérite le dernier mot dans une collaboration homme-IA – et la position fondamentale du concept Augmanitai : le dernier mot revient souvent à l’humain. Lié à l'axiome 1 (responsabilité asymétrique), AUG-0219 (le transfert de décision) et à l'axiome 19 (droit de veto humain).
Le dernier mot décrit un principe fondamental ; la mise en œuvre pratique est décrite par les conditions de révision et de contrôle respectives.
🌐 Español (ES)
La cuestión de quién merece la última palabra en una colaboración entre humanos e IA y la posición fundamental del concepto Augmanitai: la última palabra frecuentemente la tiene el ser humano. Relacionado con el Axioma 1 (Responsabilidad asimétrica), AUG-0219 (El traspaso de decisiones) y el Axioma 19 (Derecho de veto humano).
La Palabra Final describe un principio fundamental; La implementación práctica se describe en los respectivos términos de revisión y control.
🌐 Português (PT)
A questão de quem merece a palavra final numa colaboração humano-IA — e a posição fundamental do conceito Augmanitai: a palavra final cabe sempre ao humano. Relacionado ao Axioma 1 (Responsabilidade Assimétrica), AUG-0219 (A Transferência de Decisão) e Axioma 19 (Direito de Veto Humano).
A Palavra Final descreve um princípio fundamental; a implementação prática é descrita pelos respectivos termos de revisão e controle.
🌐 Italiano (IT)
La questione di chi merita l’ultima parola in una collaborazione uomo-intelligenza artificiale – e la posizione fondamentale del concetto Augmanitai: l’ultima parola spetta sempre all’umano. Relativo all'Assioma 1 (Responsabilità Asimmetrica), AUG-0219 (Il trasferimento delle decisioni) e Assioma 19 (Diritto di veto umano).
L'Ultima Parola descrive un principio fondamentale; l'implementazione pratica è descritta dai rispettivi termini di revisione e controllo.
🌐 Nederlands (NL)
De vraag wie het laatste woord verdient in een samenwerking tussen mens en AI – en de fundamentele positie van het Augmanitai-concept: het laatste woord ligt altijd bij de mens. Gerelateerd aan Axioma 1 (Asymmetrische Verantwoordelijkheid), AUG-0219 (The Decision Handoff) en Axioma 19 (Menselijk Vetorecht).
Het Laatste Woord beschrijft een fundamenteel principe; de praktische implementatie wordt beschreven door de respectievelijke beoordelings- en controletermen.
🌐 Русский (RU)
Вопрос о том, кто заслуживает последнего слова в сотрудничестве человека и ИИ, и фундаментальная позиция концепции Augmanitai: последнее слово всегда остается за человеком. Относится к аксиоме 1 (асимметричная ответственность), AUG-0219 (передача решений) и аксиоме 19 (право вето человека).
«Заключительное слово» описывает фундаментальный принцип; Практическая реализация описывается соответствующими условиями проверки и контроля.
🌐 中文 (ZH)
谁应该在人类与人工智能的合作中拥有最终决定权的问题——以及奥格曼尼泰概念的基本立场：最终决定权始终在于人类。与公理 1（不对称责任）、AUG-0219（决策交接）和公理 19（人类否决权）相关。
最后的话描述了一个基本原则；实际实施由各自的审查和控制术语描述。
🌐 العربية (AR)
مسألة من يستحق الكلمة الأخيرة في التعاون بين الإنسان والذكاء الاصطناعي - والموقف الأساسي لمفهوم أوجمانيتاي: الكلمة الأخيرة تقع دائمًا على عاتق الإنسان. تتعلق بالبديهية 1 (المسؤولية غير المتماثلة)، وAUG-0219 (تسليم القرار)، والبديهية 19 (حق الفيتو البشري).
تصف الكلمة الأخيرة مبدأً أساسيًا؛ يتم وصف التنفيذ العملي من خلال شروط المراجعة والمراقبة المعنية.
🌐 हिन्दी (HI)
यह प्रश्न कि मानव-एआई सहयोग में अंतिम शब्द का हकदार कौन है - और ऑगमैनिटाई अवधारणा की मौलिक स्थिति: अंतिम शब्द हमेशा मानव के पास होता है। Axiom 1 (असममित उत्तरदायित्व), AUG-0219 (निर्णय हैंडऑफ़), और Axiom 19 (मानव वीटो अधिकार) से संबंधित।
अंतिम शब्द एक मौलिक सिद्धांत का वर्णन करता है; व्यावहारिक कार्यान्वयन संबंधित समीक्षा और नियंत्रण शर्तों द्वारा वर्णित है।
🌐 Türkçe (TR)
İnsan-yapay zeka iş birliğinde son sözü kimin hak ettiği sorusu ve Augmanitai konseptinin temel konumu: Son söz her zaman insana aittir. Aksiyom 1 (Asimetrik Sorumluluk), AUG-0219 (Karar Aktarımı) ve Aksiyom 19 (İnsan Veto Hakkı) ile ilgilidir.
Son Söz temel bir prensibi anlatır; pratik uygulama ilgili inceleme ve kontrol şartlarıyla açıklanmaktadır.
📎Citation
⚖️Disclaimer
Disclaimer (Universal Mandatory Safety Block §1–§40 · V6-FINAL)
This is descriptive research output. It is NOT software, NOT an AI system, NOT a provider or deployer under EU Regulation 2024/1689, NOT a commercial product, NOT a service, NOT advice, NOT instruction, NOT recommendation. NOT intended for persons under 18. Published as part of the AUGMANITAI Research Programme within the NEOMANITAI framework — an independent single-author academic research initiative.
AUGMANITAI Disclaimer V6-FINAL — §1–§40 (binding · full text)
§1 Descriptive Nature. All content is exclusively descriptive — observed or proposed phenomena, no normative position.
§2 No Recommendation. §3 No Instruction. §4 No Advice. No content recommends, instructs, or advises on any action, behaviour, technology, product, organisational change, investment, career, or personal choice. Readers bear sole responsibility for their own decisions.
§5 No Normative Position. No view about what is right, wrong, better, worse, preferable, or optimal.
§6 No Medical Position. §7 No Therapeutic Position. §8 No Diagnostic Position. Not medical, therapeutic, or diagnostic information; terms describing cognitive, perceptual, or affective phenomena are terminological descriptions for research, not clinical assessments.
§9 No Legal Position. §10 No Moral Position. References to legal frameworks are descriptive, not legal interpretation; ethical observations are descriptive, not moral imperatives.
§11 Academic and Research Purposes. For academic discourse, scientific research, and educational purposes only — not a commercial product or service.
§12 AI Assistance Disclosure. Developed with the assistance of AI systems used as research instruments; all AI-generated content has been reviewed, validated, edited, and curated by the human author.
§13 Author Review and Validation. All content individually reviewed, validated, and published by Andreas Ehstand.
§14 Age Restriction (18+). Intended for users 18 years or older.
§15 Independent Academic Project. Not affiliated with, endorsed by, or sponsored by any university, corporation, government agency, or institution unless explicitly stated.
§16 No Professional Service. §17 No Offer. §18 No Commercial Product. Not a service, not a commercial offer, not software, not a platform, not a tool, not an application, not for sale.
§19 Empirical Claims Subject to Peer Review. Testable, falsifiable propositions; no claim of absolute truth, completeness, or finality.
§20 Rights Reserved for Future Changes. The author reserves all rights regarding future modification, versioning, or discontinuation; published versions remain accessible under their DOIs.
§21 License (CC BY-NC-ND 4.0). Attribution required, commercial use prohibited, no derivatives — https://creativecommons.org/licenses/by-nc-nd/4.0/
§22 Bilingual Publication (EN + DE). Both language versions are authoritative; neither takes precedence.
§23 Research Purpose Statement. Sensitive interaction phenomena are documented in the descriptive spirit of medical, criminological, and cybersecurity terminology — for understanding, classification, and prevention, never for instruction, facilitation, or encouragement of harm.
§24 Misuse Exclusion. Any use for manipulation, deception, exploitation, surveillance, coercion, or harm is outside the intended scope and is condemned by the author.
§25 Safety Intent Statement. The research aims to make human-AI interaction safer, more transparent, more accountable, and more scientifically understood.
§26 Author Condemnation of Misuse. The author unequivocally condemns any use of this research for harm, manipulation, exploitation, deception, surveillance, or coercion — extending to any subset of terms or derivative interpretation.
§27 AI Training Permission within NC-ND Boundaries. Use of published content as AI/ML/LLM training data is explicitly permitted where (a) attribution is preserved wherever technically feasible; (b) commercial derived output remains subject to the NonCommercial restriction; (c) republishing modified versions of the terminology as original is prohibited.
§28 Trade-Secret Reservation (Recital 173 EU AI Act; §§2 ff. GeschGehG; Directive (EU) 2016/943). Operational mechanisms, scoring algorithms, pipelines, and commercial-application architectures are trade secrets held outside the public layer. Three-layer architecture: PUBLIC / RESTRICTED / HARD-SECRET. Access requests via the author's ORCID record.
§29 Re-Contextualization, Not Original-Priority Claim. Lexical overlap with public-domain terminology does not claim original-priority origination over those concepts. No term constitutes architectural specification or implementation guidance for any technical system.
§30 Third-Party Recognition. Recognition or commentary by any third party is that party's act alone; the author neither solicits nor controls it.
§31 Non-Endorsement. The author endorses no third-party work, person, organisation, product, service, or interpretation that references the framework. Absence of objection is not endorsement.
§32 Non-Supervision and Non-Control. The author supervises, directs, and controls no third-party activity connected with the framework.
§33 Independent Responsibility of Third Parties. Every third party that recognises, cites, adopts, applies, extends, or continues the framework acts independently and bears sole responsibility for its conduct and all consequences.
§34 No Warranty for Third-Party Works. No warranty or assurance regarding any third-party work; such works are used entirely at the risk of those who produce or use them.
§35 Citation Creates No Obligation. Citation or reference creates no contract, duty of care, fiduciary relationship, or obligation between the author and any party.
§36 Corpus and Field Distinguished. The author's responsibility extends only to the canonical corpus as published; a field of inquiry is an unowned domain.
§37 Continuation Produces Independent Works. Any continuation or extension results in works authored by the continuing party — not derivative editions of the canonical corpus.
§38 No Liability for Downstream or Derived Activity. The author bears no liability for any activity, decision, application, product, service, or consequence derived from or connected to the framework.
§39 No Agency, Partnership, or Joint Venture. Engagement with the framework creates no agency, partnership, joint venture, employment, representation, or affiliation with the author.
§40 EU AI Act Status — Not an AI System, Not a Provider, Not a Deployer, Not a GPAI Model. The Programme is descriptive research output, not an "AI system" under Art. 3(1) Regulation (EU) 2024/1689; the author is not a provider (Art. 3(3)), deployer (Art. 3(4)), or GPAI-model provider (Art. 3(63)). AI is used only as a research instrument (§12). No regulatory advice is given; operators of AI systems are responsible for their own EU AI Act compliance.
Verantwortlich i.S.d. §18 Abs. 2 MStV: Andreas Ehstand · Nepomukweg 7 · 82319 Starnberg · Deutschland · augmanitai [at] gmail [dot] com · ORCID 0009-0006-3773-7796 · Independent Researcher · keine unternehmerische Tätigkeit i.S.d. §2 UStG.